Milan Health-Tech Startup Qura Raises €1.5 Million in Pre-Seed Funding
Milan-based Qura, a health-tech startup focused on providing comprehensive medical analysis and personalized healthcare plans through a subscription model, has successfully raised €1.5 million in a pre-seed funding round. The round was led by United Ventures, with additional investments from Vento and Italian Angels for Growth (IAG).
About Qura
Founded by Gio Grand, who serves as the Chief Technology Officer, and Virginia Gambardella, the company's CEO, Qura aims to fill a significant gap in the healthcare market. The platform offers a holistic approach to health management, addressing the needs of individuals experiencing subclinical symptoms such as chronic fatigue, hormonal imbalances, and digestive issues. These conditions often fall through the cracks of traditional healthcare systems, which are predominantly focused on acute care.
Investors and Funding Details
The pre-seed round was spearheaded by United Ventures, a notable venture capital firm, with contributions from Vento and Italian Angels for Growth (IAG). This funding will enable Qura to further develop its platform, which integrates AI-driven diagnostics and personalized healthcare plans.
Planned Use of Funds
While specific details on the allocation of the funds were not disclosed, the investment is expected to support Qura in expanding its technological capabilities and enhancing its service offerings. The company plans to continue refining its AI-powered platform to offer more precise and tailored health solutions to its users.
Addressing Healthcare Gaps
Qura's approach is particularly timely, given the increasing demand for preventive care solutions. Traditional healthcare systems often struggle to adequately address non-emergency health needs, leaving many individuals to seek out-of-pocket solutions. Through its integrated care pathway, Qura provides members with comprehensive blood testing conducted via partner laboratories, followed by personalized medical consultations.
Future Outlook
With the European health check-up market projected to reach €18.6 billion by 2030, Qura is well-positioned to capitalize on the growing interest in preventive and personalized healthcare solutions. The recent funding will likely accelerate its mission to deliver more effective healthcare options to those in need.
Virginia Gambardella, CEO of Qura, emphasized the importance of personalized care, stating, "Our mission is to empower individuals to take control of their health through comprehensive and personalized care solutions." As the company moves forward, it aims to continue innovating in the health-tech space and making healthcare more accessible and effective for its users.